Axonics Modulation Technologies, Inc. IPO Research Information

Axonics Modulation Technologies, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Axonics Modulation Technologies, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Axonics Modulation Technologies, Inc.	AXNX - NASDAQ	$14.00-$16.00	$15.00	$16.05	8.0 million	10/31/2018
Underwriter(s): BofA Merrill Lynch, Morgan Stanley
Co-Manager(s): Wells Fargo, SunTrust Robinson Humphrey
Industry: Health Care
Filing(s): Filed 2018-10-05 Terms Added 2018-10-22

Axonics Modulation Technologies, Inc. Quote & Chart - Click for current quote - AXNX

About Axonics Modulation Technologies, Inc. (adapted from Axonics Modulation Technologies, Inc. prospectus):
They are a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation, or SNM, solutions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "AXNX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.